Sponsor

Daehwa Pharmaceutical Co. Ltd.

495 Hanu-Ro, Hoengseong-Eup, 25228

About the sponsor

Clinical research focuses on recurrent and metastatic HER2-negative breast cancer, with interest in treatment options for patients requiring first-line systemic therapy.

HER2-negative breast cancer
Recurrent disease
Metastatic disease

The sponsor’s current research activity is centered on oncology care in advanced breast cancer settings.

About Specializations

Daehwa Pharmaceutical Co. Ltd. runs clinical trials in conditions such as Breast cancer metastatic, Breast cancer recurrent, Human epidermal growth factor receptor negative, among others.

All trials